Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • No 'bird brains'? Crows exhibit advanced relational thinking, study suggests

  • In one aspect of vision, computers catch up to primate brain

  • A clear, molecular view of how human color vision evolved

  • A Facebook application knows if you are having a bad day and tells your teacher

  • Personalized advertising attracts more attention and makes contents of ads easier to remember

  • Lost memories might be able to be restored, suggests research into marine snail

  • Family criticizing your weight? You might add more pounds

  • Early exposure to antidepressants affects adult anxiety, serotonin transmission

  • Cocaine, amphetamine users more likely to take their own lives

  • New technology advances eye tracking as biomarker for brain function, recovery from brain injury

  •